ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis.

Marjan Gharagozloo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.